Lower coverage of EGFR was observed in the 23 HNSCC tumors compared to the U87MG cell line (exon 1 peak coverage in the HNSCC tumors ranged from 2–94 reads as compared to 597 reads in the cell line). Here, EGFR is linked to head and neck squamous cell carcinoma.